Skip to main navigation
Skip to search
Skip to main content
University of Luebeck Home
English
Deutsch
Home
Research Units
Experts
Publications
Projects
Datasets
Prizes
Spin-Offs
Activities
Media
Search by expertise, name or affiliation
Nonsteroidal Anti-inflammatory Use and LRRK2 Parkinson's Disease Penetrance
the Michael J. Fox Foundation LRRK2 Cohort Consortium
Institute of Neurogenetics
University of California San Francisco
University Health Network
University of Barcelona
Stanford University
Sorbonne Universite
Istituti Clinici di Perfezionamento
University of Western Australia
University of Tubingen
University of Kiel
Universidade de Lisboa
Service de Neurologie CHU Mustapha
Griffith University
University of Sydney
National Hospital Organization, Japan
Singapore General Hospital
Mount Sinai School of Medicine
2
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Nonsteroidal Anti-inflammatory Use and LRRK2 Parkinson's Disease Penetrance'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Pharmacology, Toxicology and Pharmaceutical Science
Acetylsalicylic Acid
21%
Anti-Inflammatory Drug
100%
Ibuprofen
21%
Inflammation
7%
Leucine Rich Repeat Kinase 2
100%
Non-Steroidal Anti-Inflammatory Drug
50%
Parkinson's Disease
100%
Neuroscience
Anti-Inflammatory
100%
Aspirin
21%
Ibuprofen
21%
Leucine Rich Repeat Kinase 2
100%
Non-Steroidal Anti-Inflammatory Drug
50%
Parkinson's Disease
100%
Agricultural and Biological Sciences
Aspirin
25%
Leucine
100%
Penetrance
100%